mitoxantrone (Novantrone) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

Other important side effects include

  • heart failure,
  • suppression of the immune system, and
  • liver toxicity.

GENERIC AVAILABLE: Yes.

PRESCRIPTION: Yes.

PREPARATIONS: Injection: 20/10, 25/12.5, and 30 mg/15 ml

STORAGE: Mitoxantrone should be stored at room temperature, 15 C to 25 C (59 F to 77 F). It should not be frozen.

DOSING: Mitoxantrone is given by intravenous infusion. The recommended dose for secondary progressive multiple sclerosis is 12 mg/m2 infusion every 3 months. The lifetime cumulative dose is 140 mg/m2. The dose for nonlymphocytic leukemia is 12 mg/m2/day on days 1-3 with cytarabine 100 mg/m2/day on days 1-7. The dose for hormone-refractory prostate cancer is 12 to 14 mg/m2 every 21 days.

DRUG INTERACTIONS: Combining mitoxantrone with other drugs that, like mitoxantrone, suppress the immune system leads to severe immune suppression and an increased risk of infections.

PREGNANCY: Mitoxantrone should not be administered to pregnant women due to risk of severe harm to the fetus.

NURSING MOTHERS: Mitoxantrone is excreted in breast milk and should not be used while breastfeeding.

Medically reviewed by Eni Williams, PharmD


Medically Reviewed by a Doctor on 7/9/2015


Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index